Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
https://www.zacks.com/stock/news/2218010/amgen-amgn-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2218010
Jan 30, 2024 - Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
https://www.zacks.com/stock/news/2217364/will-amgen-amgn-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2217364
Jan 29, 2024 - Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
Is Amgen a Good Dividend Stock to Buy Right Now?
https://www.fool.com/investing/2024/01/29/is-amgen-a-good-dividend-stock-to-buy-right-now/?source=iedfolrf0000001
Jan 29, 2024 - Its diverse product mix and strong fundamentals make a decent case.
0
Key Takeaways From JNJ's (JNJ) Q4 Earnings Presentation
https://www.zacks.com/stock/news/2216453/key-takeaways-from-jnj-s-jnj-q4-earnings-presentation?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2216453
Jan 26, 2024 - J&J's (JNJ) Innovative Medicines as well as MedTech units outperform expectations in the fourth quarter. Here we discuss some highlights of its performance in the fourth quarter.
0
Top Research Reports for Novartis, Amgen & Palo Alto Networks
https://www.zacks.com/commentary/2214881/top-research-reports-for-novartis-amgen-palo-alto-networks?cid=CS-ZC-FT-research_daily-2214881
Jan 24, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), Amgen Inc. (AMGN) and Palo Alto Networks, Inc. (PANW).
0
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2210202/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2210202
Jan 15, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
https://www.zacks.com/stock/news/2209160/amgen-amgn-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2209160
Jan 11, 2024 - Amgen (AMGN) reachead $303.10 at the closing of the latest trading day, reflecting a -0.48% change compared to its last close.
0
Top Stock Reports for Apple, UnitedHealth & Exxon Mobil
https://www.zacks.com/commentary/2205630/top-stock-reports-for-apple-unitedhealth-exxon-mobil?cid=CS-ZC-FT-research_daily-2205630
Jan 08, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), UnitedHealth Group Incorporated (UNH) and Exxon Mobil Corporation (XOM).
0
Here's How Much a $1000 Investment in Amgen Made 10 Years Ago Would Be Worth Today
https://www.zacks.com/stock/news/2205532/here-s-how-much-a-1000-investment-in-amgen-made-10-years-ago-would-be-worth-today?cid=CS-ZC-FT-tale_of_the_tape|investing_$1000-2205532
Jan 04, 2024 - Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
0
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
https://www.fool.com/investing/2023/12/29/there-are-only-5-dow-stocks-i-wouldnt-buy-in-2024/?source=iedfolrf0000001
Dec 29, 2023 - There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.
0